MYRIAD GENETICS INC
Offers genetic tests for oncology, women's health, and mental health for personalized care.
MYGN | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 322 NORTH 2200 WEST, 84116 SALT LAKE CITY
- Website:
- https://myriad.com/
- Sector:
- Human health and social work activities
- Industry:
- Other residential care activities
Description
Myriad Genetics, Inc. is a genetic testing and precision medicine company dedicated to advancing health and well-being through personalized genetic insights. The company develops and commercializes a portfolio of molecular diagnostic tests that empower patients and healthcare providers to detect disease risk, guide treatment decisions, and improve clinical outcomes. Myriad's key focus areas include oncology (hereditary cancer risk, tumor genomics for therapy selection, recurrence risk), women’s health (prenatal and carrier screening), and mental health (pharmacogenomics to guide medication selection). By translating complex genetic and genomic information into actionable answers, Myriad supports personalized care throughout the patient's journey, from prevention and detection to treatment.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all MYRIAD GENETICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MYRIAD GENETICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MYRIAD GENETICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||